Drug
Eptacog Alfa OR Pdfvii
Eptacog Alfa OR Pdfvii: highest development phase Phase 1, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Eptacog alfa (activated) or pdFVII NCT02470871 | Phase 1 | Congenital Coagulation Factor VII Deficiency |
Latest
No recent events.
Follow Eptacog Alfa OR Pdfvii on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.